- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Konica’s Regius
Konica of Wayne, NJ, became the latest company to join the digital x-ray party when it received 510(k) clearance on June 19 from the Food and Drug Administration for Regius, an x-ray digitization system based on storage phosphor technology. Konica
Konica of Wayne, NJ, became the latest company to join the digital x-ray party when it received 510(k) clearance on June 19 from the Food and Drug Administration for Regius, an x-ray digitization system based on storage phosphor technology. Konica introduced Regius at last years Radiological Society of North America meeting as a system for conducting digital chest and abdomen studies (SCAN 11/26/97).
Although Regius is similar to computed radiography in that it is based on storage phosphor, unlike CR it does not require storage phosphor plates to be removed and taken to a separate reader. Images can be acquired and processed in 20 seconds and sent directly into a DICOM-based network. Konica has already installed over 20 Regius systems in Japan.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
